ALLR

ALLARITY THERAPEUTICS, INC.

ALLR · CIK 1860657 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20212024
Net Income−$25M
20212024
Operating CF−$17M
20212024
Free Cash Flow−$18M
20212024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Revenue————
Cost of Revenue————
Gross Profit—$-0.0B——
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-15.65$-10.26$-2.21$-4.19
EPS (Diluted)—$-10.26$-2.21—

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Total Assets$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$-0.0B$-0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$0.0B$0.0B$0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.0B$0.0B$-0.0B$0.0B
← Companies